Skip to main content
MDTHealthcare

Medtronic Plc (MDT) Insider Trading

In the last 90 days, 3 Medtronic Plc (MDT) insiders reported no open-market purchases and 3 sales totaling $5,889,203. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Michael MarinaroEVP, Pres MedSurg and AmericasSale10,420$96.00$1,000,320
Oct 15, 2026Geoffrey MarthaChairman and CEOSale50,000$95.00$4,750,000
Sep 16, 2026Harry Skip KiilEVP & President CardiovascularSale1,483$93.65$138,883
Jul 8, 2026Matthew R. WalterSVP, Chief HR OfficerSale3,102$83.15$257,931
Jun 8, 2026Harry Skip KiilEVP & President CardiovascularSale4,189$80.44$336,965

Common questions

MDT insider trading FAQ

Are MDT insiders buying or selling?
Over the last 90 days, MDT insiders were net sellers, reporting $0.00 of open-market purchases and $5,889,203 of sales.
When was the last MDT insider purchase?
No open-market insider purchase of Medtronic Plc stock was reported in the last 90 days.
Where does MDT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Medtronic Plc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.